Lecture1-Chronic Disease Management
-
Upload
leyla-majunda -
Category
Documents
-
view
219 -
download
0
Transcript of Lecture1-Chronic Disease Management
-
7/30/2019 Lecture1-Chronic Disease Management
1/29
Majid Ali
October 2010
School of PharmacyUniversity of Hertfordshire
Chronic Disease Management
-
7/30/2019 Lecture1-Chronic Disease Management
2/29
Learning Outcomes
At the end of the session students shouldbe able to identify:
What is chronic disease (with examples)
Increasing rate and seriousness of chronicdiseases
How and why pharmacists can be helpful
Tools pharmacists can use to manage chronic
diseases
Changing role of pharmacists and community
pharmacy in context of New NHS Vision and
Pharmacy White Paper (relevance to chronic
-
7/30/2019 Lecture1-Chronic Disease Management
3/29
A Chronic Disease is Defined as:
a disease lasting for one or more years,
with no cure and worsening symptoms,
which has the ability to limit lifestyle
-World Health
Organisation
-
7/30/2019 Lecture1-Chronic Disease Management
4/29
Examples of Chronic Diseases
Arthritis
Diabetes
Epilepsy
Heart diseases and strokeAsthma
COPD
-
7/30/2019 Lecture1-Chronic Disease Management
5/29
Why is chronic disease an
important health issue?
Social circumstances affect the chance ofhaving a chronic disease to a large extent
Some patients have multiple chronic
diseases, which makes their careparticularly complex
A small number of patients and diseases
account for a disproportionate amount ofhealthcare use (especially hospital care)
-
7/30/2019 Lecture1-Chronic Disease Management
6/29
Did you know??
35 000 000
people died fromchronic diseases
in 2005
-
7/30/2019 Lecture1-Chronic Disease Management
7/29
Global Mortality: A Select Comparison of
Leading Causes of Death (2004-2030)
-
7/30/2019 Lecture1-Chronic Disease Management
8/29
World Health Statistics 2008 Report
Chronic diseases, such as heart disease
and stroke, are overtaking infectious
diseases like tuberculosis and malaria as
the main causes of death across the world
Over the next 25 years the number of
deaths attributed to non-communicable
disease will rise significantly as the worldspopulation continues to live longer
-
7/30/2019 Lecture1-Chronic Disease Management
9/29
By 2030 the top four causes of death will be
ischaemic heart disease, stroke, chronic
obstructive pulmonary disease and lower
respiratory disease (mostly pneumonia)
Deaths from HIV are expected to rise to a
peak in 2012 when the disease will be
responsible for ending 2.4 million lives
In 2012 chronic disease and death
following a road traffic accident are
expected to be responsible for around a
-
7/30/2019 Lecture1-Chronic Disease Management
10/29
Chronic Diseases in England
60% of adults in England
report a chronic healthproblem
-
7/30/2019 Lecture1-Chronic Disease Management
11/29
Diabetes Mellitus (DM): 1.3m people with DM andperhaps another million undiagnosed
COPD: 600,000 people
Asthma: 3.7madults and 1.5m children
Arthritis: 8.5m
Epilepsy: 400,000 sufferers England & Wales
Mental illness: 1 in 6 of the population, including 1in 10 children
8.8m people in England have long term illness that
severely limits their day to day ability to cope.
-
7/30/2019 Lecture1-Chronic Disease Management
12/29
Risk Factors for Chronic
Diseases
Most chronic diseases are caused by asmall number of preventable risk factors
such as: unhealthy diet, lack of exercise
and tobacco use.
-
7/30/2019 Lecture1-Chronic Disease Management
13/29
-
7/30/2019 Lecture1-Chronic Disease Management
14/29
Management of Chronic
Diseases
Chronic diseases can be bettermanaged through
Increased support for self care
Strengthening usual primary care
Offering responsive specialist care
Managing vulnerable cases by
anticipating their needs
-
7/30/2019 Lecture1-Chronic Disease Management
15/29
Components Required for Good
Chronic Disease Management
Identifying patients with chronic disease
Using information systems to access dataabout individuals and populations
Stratifying patients by risk
Involving patients in their own care
Co-ordinating care
Using multidisciplinary teams
-
7/30/2019 Lecture1-Chronic Disease Management
16/29
What models of chronic disease
management are being used?
The overall model for chronic disease
management requires a whole system approach
and this has been divided into three levels (nextslide):
-
7/30/2019 Lecture1-Chronic Disease Management
17/29
Kaiser Model
of Care
o t
Detecting poorly controlled conditions rapidly
Identifying patients at risk and initiating actions to prevent
deterioration
Ensuring medicines are used to optimum effect
Independent & Supplementary prescribing
It could also involve disease-specific care managers
(pharmacists with specific areas of expertise)
Limiting inappropriate hospital admissions by managing
medicines in the community
Ensuring hospital discharge is safe by providing medical
support
Mentoring APNs (advanced primary nurses) or acting as
Advanced Primary Practitioners.
health promotion and counselling
practical help, providing compliance
aids if necessary
OTC advice
-
7/30/2019 Lecture1-Chronic Disease Management
18/29
Why should pharmacist getinvolved?
Easily accessed healthcare point
It is estimated that half of all people witha chronic disease fail to take theirmedicines properly
Pharmacists have the medical expertise
and accessibility to help improve thisnoncompliance
-
7/30/2019 Lecture1-Chronic Disease Management
19/29
Gives them opportunity to help patients,keep them out of hospital, educate them
and their carer about their medication
Be recognised in local team with otherhealth and social care professional
Become responsible in medication
review (NSF older people) Enhanced reputation, better use of
pharmacists skills and job satisfaction
-
7/30/2019 Lecture1-Chronic Disease Management
20/29
Tools Pharmacists can Use to
Help with Chronic Diseases
History taking Medicines use reviews (MURs)
Patient profiles
Health promotion Ward rounds
Outpatient clinics
Chronic diseases management clinics
Repeat prescriptions
Patient group directions (PGDs)
Pharmacist prescribing
Expert patient
-
7/30/2019 Lecture1-Chronic Disease Management
21/29
Services for diabetes such as bloodtesting, foot checks and retinal
screening in community pharmacies
Implications of the new GMS andpharmacy contract for improving the
quality of care of people with long-term
conditions US style managed care providers and
pharmaceutical companies in the field of
chronic disease management
-
7/30/2019 Lecture1-Chronic Disease Management
22/29
The Role of Pharmacy in the New
Vision of the NHS Easier access to medicines
Easier and more convenient for patients to get
the medicines they need safely
Expanding the range of medicines that
pharmacies can provide without a prescription
-
7/30/2019 Lecture1-Chronic Disease Management
23/29
Increasing the range of healthcareprofessionals who can prescribe drugsto patients
New pharmacies to locate in areas suchas one-stop primary care centres
DoH will facilitate the establishment ofpharmacies intending to open more than
100 hours a week or to operate whollyvia mail order or the internet
-
7/30/2019 Lecture1-Chronic Disease Management
24/29
Pharmacy White Paper 2008
How pharmacy can contribute in chronicdisease management
Health campaigns aimed at improving
awareness of the risks associated with certainlong-term conditions
Improving medicines-related care for people
with long-term conditions to reduce
emergency admissions Screening services within national guidelines
following UK National Screening Committee
recommendations to identify those at risk of
developing, or who have already developed, a
-
7/30/2019 Lecture1-Chronic Disease Management
25/29
Medication reviews and adherenceprogrammes to improve medicine taking,
tailored for particular conditions, including
advice on new medicines, side effects, etc
Monitoring with dedicated clinics using
prescribing or patient group directions to help
control cholesterol for those on statins and
blood pressure for those on antihypertensives Signposting to social care information and
aligning care plans
Prevention and early detection of some
cancers
-
7/30/2019 Lecture1-Chronic Disease Management
26/29
Take Aways
Chronic disease is a disease lasting forone or more years, with no cure and
worsening symptoms, which has the
ability to limit lifestyle e.g. diabetes,asthma etc.
60% of worldwide deaths in 2005 were
due to chronic diseases By 2030 top three leading causes
(diseases) of deaths will be chronic
diseases
-
7/30/2019 Lecture1-Chronic Disease Management
27/29
Chronic disease management requiresidentification, risk stratification and
individualised patient management
Role of pharmacist as main point of contact isessential in chronic disease management
Pharmacists can utilise MURs, PMRs,
medication profiles, PGDs, expert patients in
chronic disease management Government in the form of New NHS Vision
and Pharmacy White Paper has recognised
the potential role of pharmacists in chronic
disease management
-
7/30/2019 Lecture1-Chronic Disease Management
28/29
Useful Resources
http://www.psnc.org.uk/index.php?type=page&pid=19&k=5
http://www.who.int/topics/chronic_diseases/en/
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/D
H_4075214
http://www.dh.gov.uk/en/Publicationsandstatistic
s/Publications/PublicationsPolicyAndGuidance/DH_4070097
http://www.psnc.org.uk/index.php?type=page&pid=19&k=5http://www.psnc.org.uk/index.php?type=page&pid=19&k=5http://www.who.int/topics/chronic_diseases/en/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4070097http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4075214http://www.who.int/topics/chronic_diseases/en/http://www.psnc.org.uk/index.php?type=page&pid=19&k=5http://www.psnc.org.uk/index.php?type=page&pid=19&k=5 -
7/30/2019 Lecture1-Chronic Disease Management
29/29
Image on slide6 retrieved from
http://images.google.co.uk/imgres?imgurl=http://patientsandpate
nts.files.wordpress.com/2008/11/dpm-global-health-
report2.jpg&imgrefurl=http://patientsandpatents.wordpress.com/2
008/11/10/cancer-cardiovascular-and-other-type-1-diseases-will-
cause-over-three-quarters-of-all-deaths-by-
2030/&usg=__alFnOVeHgFGtajlEk3QnjxhjWSQ=&h=497&w=66
0&sz=64&hl=en&start=5&um=1&tbnid=JlI9WZXtgusNDM:&tbnh
=104&tbnw=138&prev=/images%3Fq%3Dprojected%2Bmain%2
Bcauses%2Bof%2Bdeath%2Bworldwide%2B2008%26ndsp%3D18%26hl%3Den%26rlz%3D1T4ADBF_en-
GBGB335GB335%26sa%3DG%26um%3D1